Recovery Research Market

KPV

A short peptide fragment associated with gut-barrier, inflammatory, and tissue-soothing discussions in the peptide market.

InflammationGut HealthResearch Market

Also appears in: Immune · Skin & Cosmetic

Price compare
81 tracked offers across 81 vendors · 13 dosages
Best trust-adjusted value: Peptide Supply Co · Strong trust · $1.89/mg
From
$1.89/mg
Status
Research Market

This name primarily lives in the research market and should not be read like an approved pharmaceutical product.

Category
Recovery

Primary lane: Recovery. Also surfaces under Immune, Skin & Cosmetic for browsing and discovery.

Aliases
0

No major aliases are tracked for this profile yet.

Signal depth
Low

No FDA label signal · 0 trials · 132 PubMed results

Preclinical
Research evidence

Current evidence for KPV is limited to laboratory or animal studies — there are no name-matched human trials with reported results. Any claims about effects in people are not yet backed by clinical data.

KPV has no clinical trials that name it and 132 PubMed-indexed publications and is not FDA-approved. Current evidence is preclinical or mechanistic.

Human data
Lab / animal only
Trial quality
No human trials
Outcomes
No human trials
Replication
Multiple papers
Literature
High-impact
Molecular Therapy · 181 citations Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis Gastroenterology · 122 citations PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation Solar Energy · 112 citations KPV: A clear-sky index for photovoltaics Journal Article Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARγ pathway in HepG2 cells. Journal Article A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. Journal Article Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers.
Evidence history

Re-checked nightly against the registries — tracked since 2026-07-09. No band changes yet.

Grades evidence strength, not efficacy or safety. Research-use context; not medical advice. Graded 2026-07-13 from PubMed, ClinicalTrials.gov, ISRCTN, openFDA, Health Canada, and OpenAlex — computed deterministically and refreshed nightly, with a retraction check. How we grade →

What KPV is

KPV is a short peptide fragment that often appears in gut-health, inflammation, and repair-oriented product lines. It is especially common in blends marketed around recovery or skin support.

Why it matters

KPV shows how the recovery category extends beyond tendon-and-muscle peptides into gut and inflammatory signaling.

Regulatory context

KPV is not FDA approved in the United States and is best treated as a research-market peptide.

Practical reading note

If a vendor frames KPV as a cure-all, that is usually a sign to slow down and separate plausible mechanistic interest from broad consumer claims.